Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News OrganiGram Holdings Inc T.OGI

Alternate Symbol(s):  OGI

Healthcare Cannabis
Organigram Holdings Inc. operates through its subsidiaries. The Company’s major wholly owned subsidiaries include Organigram Inc., 10870277 Canada Inc., The Edibles and Infusions Corporation (EIC), and Laurentian Organic Inc. (Laurentian). Organigram Inc. is a licensed producer (LP) of cannabis, cannabis-derived products and cannabis infused edibles in Canada. It is focused on producing... see more

Recent & Breaking News (TSX:OGI)

Organigram Closes Second Tranche of Previously Announced BAT Private Placement Investment

Business Wire September 3, 2024

Organigram Reports Third Quarter Fiscal 2024 Results

Business Wire August 13, 2024

Organigram Product Development Collaboration Completes Landmark Clinical Study on Nanoemulsion Technology

Business Wire August 7, 2024

Organigram to Report Third Quarter Fiscal 2024 Results on August 13, 2024

Business Wire August 6, 2024

Organigram Announces Appointment of Craig Harris to Board of Directors

Business Wire July 29, 2024

Organigram to Bolster Auto-Flower and Rare Cannabinoid Portfolio with Partial Third Tranche Investment of US $1M into Phylos

Business Wire July 24, 2024

Organigram Invests in Sanity Group, a Leading German Cannabis Company

Business Wire June 25, 2024

Organigram Signs Three Year Supply Agreement with Avida Medical in UK

Business Wire May 28, 2024

Organigram Reports Second Quarter Fiscal 2024 Results

Business Wire May 14, 2024

Organigram to Report Second Quarter Fiscal 2024 Results on May 14, 2024

Business Wire May 8, 2024

Organigram Recognized for Executive Gender Diversity by the Globe & Mail's Women Lead Here Report for the Fourth Consecutive Year

Business Wire April 8, 2024

Organigram's Popular SHRED Brand Surpasses $200 Million in Yearly Retail Sales

Business Wire April 3, 2024

Organigram Successfully Closes Previously Announced Underwritten Public Offering

Business Wire April 2, 2024

Organigram looks to raise capital as cannabis stocks surge

Trevor Abes  March 27, 2024

Organigram Announces Pricing of Overnight Marketed Public Offering

Business Wire March 27, 2024

Organigram Announces Launch of Overnight Marketed Public Offering

Business Wire March 26, 2024

Organigram Invests in U.S. Based Open Book Extracts Representing Inaugural Jupiter Investment

Business Wire March 26, 2024

Organigram Receives Health Canada's Final Redetermination on Jolts

Business Wire March 22, 2024

Organigram Applauds the Standing Committee on Finance's Recommendation on Excise Duty

Business Wire February 28, 2024

Organigram Reports First Quarter Fiscal 2024 Results

Business Wire February 13, 2024